Results 121 to 130 of about 182,908 (236)

Nanomaterial‐based immune therapeutic strategies in neurodegenerative diseases

BMEMat, EarlyView.
This review highlights the immunomodulatory potential of nanomaterials (NMs) in treating neurodegenerative diseases (NDs). It focuses on their roles in regulating innate and adaptive immune responses to maintain immune homeostasis. By providing insights into these mechanisms, the review lays the groundwork for innovative NMs therapeutic strategies to ...
Xinru Zhou, Jia Liu, Shulin Lai, Suhan Yin, Bingmin Luo, Longquan Shao, Yiyuan Kang   +6 more
wiley   +1 more source

Reprogramming tumor immune microenvironment by ultrasound‐responsive nanoplatforms for enhanced cancer immunotherapy

BMEMat, EarlyView.
Ultrasound‐responsive nanoplatforms reprogram the tumor immune microenvironment by targeting tumor cells, immune cells, and non‐immune stromal cells to enhance the efficacy of cancer immunotherapy. Abstract Cancer immunotherapy represents a significant advancement in cancer treatment by enhancing the specific recognition and elimination of cancer cells.
Shilong Zhao, Rui Qu, Zan Dai, Xiqun Jiang, Xu Zhen   +4 more
wiley   +1 more source

Alteration of innate lymphoid cell homeostasis mainly concerns salivary glands in primary Sjögren's syndrome. [PDF]

RMD Open, 2023
Kawka L, Felten R, Schleiss C, Fauny JD, Le Van Quyen P, Dumortier H, Monneaux F, Gottenberg JE.   +7 more
europepmc   +1 more source

The myth of the metabolic baseline: sleep–wake cycles undermine a foundational assumption in organismal biology

Biological Reviews, EarlyView.
ABSTRACT Basal and standard metabolic rate (BMR and SMR) are cornerstones of physiological ecology and are assumed to be relatively fixed intrinsic properties of organisms that represent the minimum energy required to sustain life. However, this assumption is conceptually flawed. Many core maintenance processes underlying SMR are temporally partitioned
Helena Norman, Daphne Cortese, Amelia Munson, Jan Lindström, Shaun S. Killen   +4 more
wiley   +1 more source

Innate lymphoid cell heterogeneity and etiology-specific reprogramming in hepatocellular carcinoma. [PDF]

NPJ Precis Oncol
Lee YH, Chuah S, Leow WQ, Hazirah SN, Wasser M, Chung A, Goh BKP, Chow PKH, Albani S, Lee J, Lim TKH, Dan YY, Lee SG, Tai D, Chen J, Liu H, Chew V.   +16 more
europepmc   +1 more source

Interleukin-33 increases type 2 innate lymphoid cell count and their activation in eosinophilic asthma. [PDF]

Clin Transl Allergy, 2023
Sun F, Zou W, Shi H, Chen Z, Ma D, Lin M, Wang K, Huang Y, Zheng X, Tan C, Chen M, Tu C, Wang Z, Wu J, Wu W, Liu J.   +15 more
europepmc   +1 more source

Engineering Lipid Nanoparticles for Precision RNA Delivery: Design Principles, Targeting Strategies, and Clinical Prospects

Cancer Nexus, EarlyView.
ABSTRACT Lipid nanoparticles (LNPs) represent the most clinically advanced platform for RNA delivery and have enabled major breakthroughs in vaccines and gene therapies. However, their broader application is still limited by inefficient extrahepatic delivery, immunogenicity, and insufficient control over tissue‐ and cell‐specific targeting. This review
Yu Han, Ying Wang, Xintao Gao, Yan Lei, Yantao Li, Zhiyong Tang   +5 more
wiley   +1 more source

Elementary immunology [PDF]

, 2017
Gogolák, Péter, Koncz, Gábor
core  

Decoding innate lymphoid cell heterogeneity and plasticity in colorectal cancer. [PDF]

Clin Transl Med
Zhang S, Fu Q, Xu Z, Wang S, You G, Su X, Yuan X, Liu C, Liu C, Zhang C, Liu B, Gong Y.   +11 more
europepmc   +1 more source

Editorial: Transcriptional and epigenetic control of T and innate lymphoid cell development and function. [PDF]

Front Immunol, 2023
Xu W, Verykokakis M.
europepmc   +1 more source